GIRAUDO BRYAN received a stock award from PROTAGONIST THERAPEUTICS, INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/6/2026ACC: 0001104659-26-001477
Director
Since Jun 2019
+6.46K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
6.46K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.69K
Price / share
—
Trade value
—
% of position
17.8%
1/2/2026
15.13K→17.82K
Total
Net shares
+2.69K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | A · Award | +2.69K | — | — | 17.8% | 15.13K | 17.82K |
| Total | +2.69K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
3.76K shares
Shares
+3.76K
Strike price
87.18
Held after
3.76K
Exercisable
—
1/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock3.76K shares | 1/2/2026 | A · Award | +3.76K | 87.18 | — | 3.76K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned8K
Total
8K indirect8K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 8K | Indirect |
| Total | 8K | 8K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported